| P2093 | author name string | S Sayed | |
| | E Abdel-Rasheed | |
| | H A Raafat | |
| | H El-Fishawy | |
| | M M Nasrallah | |
| | T A Gheita | |
| P2860 | cites work | Insulin resistance and obesity in a mouse model of systemic lupus erythematosus | Q80284406 |
| | Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire | Q80845130 |
| | Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis | Q82835514 |
| | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| | Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics | Q28300402 |
| | Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 |
| | HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study | Q30700439 |
| | Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients | Q33357081 |
| | Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 |
| | Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 |
| | Development of the multiple metabolic syndrome: an epidemiologic perspective | Q34756502 |
| | Autoimmunity, oxidized LDL and cardiovascular disease | Q35172129 |
| | Treatment of severe proliferative lupus nephritis: the current state | Q35201234 |
| | Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus | Q35552185 |
| | Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome | Q35552883 |
| | High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors | Q35638692 |
| | Systemic lupus erythematosus, atherosclerosis, and autoantibodies | Q36242825 |
| | The role of innate and adaptive immunity to oxidized low-density lipoprotein in the development of atherosclerosis | Q36242852 |
| | 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus | Q36290168 |
| | Atherogenesis in rheumatology | Q36458127 |
| | Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association | Q37033339 |
| | The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus | Q40974327 |
| | Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. | Q43275139 |
| | Risk factors for cardiovascular disease in systemic lupus erythematosus | Q43767819 |
| | Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. | Q44412972 |
| | Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 |
| | Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices | Q44589658 |
| | Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study | Q44652580 |
| | Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. | Q44808071 |
| | Measuring the quality of life of cancer patients: a concise QL-index for use by physicians. | Q51260397 |
| | Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. | Q51581413 |
| | Elevated Levels of Authentic Plasma Hydroperoxides in NIDDM | Q51586175 |
| | Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis | Q77794855 |
| | Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus | Q77909409 |
| | Altered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus | Q80038527 |
| P433 | issue | 2 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| | metabolic syndrome | Q657193 |
| | insulin resistance | Q1053470 |
| | comorbidity | Q1414874 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 172-177 | |
| P577 | publication date | 2013-03-01 | |
| P1433 | published in | Zeitschrift fuer Rheumatologie | Q15763293 |
| P1476 | title | Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness | |
| P478 | volume | 72 | |